Stay updated on Nivolumab Combo Neoadjuvant IBC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combo Neoadjuvant IBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combo Neoadjuvant IBC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The clinical trial record appears unchanged, with the same study details and page content.
    Difference
    0.1%
    Check dated 2026-11-14T13:25:15.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The record now presents details for the completed Phase 2 trial of nivolumab with chemotherapy for inflammatory breast cancer, including its design, eligibility criteria, outcome measures, and study documents.
    Difference
    58%
    Check dated 2026-11-07T12:35:57.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision changed from v3.7.2 to v3.8.0; the study record remains unavailable behind a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T13:16:59.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A site-wide banner announces an NIH transition notice about using “Super Intelligence” in place of “Artificial Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-24T13:06:42.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision marker changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T13:22:52.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The inflammatory breast cancer trial record and its study details have been replaced by a 403 Forbidden page.
    Difference
    20%
    Check dated 2026-10-10T14:52:51.000Z thumbnail image

Stay in the know with updates to Nivolumab Combo Neoadjuvant IBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo Neoadjuvant IBC Clinical Trial page.